# Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF)

> **NCT05809011** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 120 (estimated)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT05809011
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-24
- **Primary completion:** 2025-11
- **Final completion:** 2025-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05809011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05809011, "Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05809011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*